Intermediate-risk - Globe Thesis

Keyword [Intermediate-risk] Result: 1 - 20 \| Page: 1 of 3
1.	The Efficacy Of Brachytherapy On The Patients With Clinically Localized Intermediate And High-risk Prostate Cancer
2.	Risk Factor Of Locoregional Recurrence And Role Of Radiotherapy After Postmastectomy For Early Stage Intermediate Risk (T1-2N1M0) Breast Cancer
3.	The Value Of Modified Radical Hysterectomy In Intermediate Risk Subgroup Of FIGO Stage Ⅰ Endometroid Adenocarcinoma
4.	Clinical Study On Reteplase Thrombolysis Therapy In Patients With Acute Intermediate-risk Pulmonary Thromboembolism
5.	Clnical Study Of Adjuvant Chemotherapy With Nonanthracyclin Regimens For Eldely And Postmenopausal Breast Cancer With Low Risk Or Intermediate Risk
6.	The Risk Factor Analysis For Stroke In Non-valvular Atrial Fibrillation Patients With Low-intermediate Risk CHADS2Score
7.	Prognosis And Adjuvant Treatment Of Surgically Treated Stage ⅠB-ⅡA Cervical Cancer Patients With Intermediate-risk Factors
8.	Prognosis Of Stage Ⅰ B-ⅡA Squamous Cell Cervical Cancer With Intermediate Risk Factors Treated By Adjuvant Chemotherapy Or Radiotherapy:a Comparative Study
9.	Effect Of Azacitidine In Treatment Of High And Intermediate Risk Myelodysplastic Syndrome:7 Cases And Review Of The Literature
10.	Clinical Study On Mixed Transplantationin In The Treatment Of Low-intermediate Risk Acute Leukemia
11.	What Postoperative Adjuvant Therapy To Choose And The Corresponding Prognosis To Cervical Carcinoma Patients With Different Recurrence Risk Factors
12.	Thrombolysis For Acute Intermediate-risk Pulmonary Embolism: A Meta-analysis
13.	A Retrospective Study Of Intermediate/High-dose Cytarabine Consolidation Therapy In Younger Adults With Acute Myeloid Leukemia With Favorable/Intermediate Risk Cytogenetics
14.	A Prospective Trial Of ⅠB-ⅡA Cervical Squamous Cancer With Intermediate Risk Factors Treated By Chemotherapy Or Chemoradiation
15.	Clinical Effect Investigation Of Adjuvant Chemotherapy In Patients With Intermediate Risk Factors After Radical Surgery In Early Stage Cervical Adenocarcinoma
16.	The Clinical Curative Effect Analysis Of Thrombolysis And Anticoagulation In Intermediate-risk Acute Pulmonary Embolism
17.	Clinical Observation On Jia Wei Lan Zhou Prescription Combined With Cyclosporine A In The Treatment Of Patients With Low Risk Or Intermediate Risk-1 Myelodysplastic Syndrome
18.	Mutational Spectrum And Prognostic Factors Of Intermediate-risk Cytogenetics Acute Myeloid Leukemia With FLT3-ITD Mutation
19.	The Landscape Of Gene Mutations In Acute Myeloid Leukemia(AML)patients With Intermediate-risk-cytogenetic-group
20.	The Influencing Factors On The Efficacy Of Low Dose Radioactive Iodine Treatment In Patients With Low-to Intermediate-risk Differentiated Thyroid Cancer
<<First <Prev Next> Last>> Jump to